Adjuvants: current status, clinical perspectives and future prospects
Author:
Publisher
Elsevier BV
Subject
Immunology
Reference53 articles.
1. Impediments to the Development of Additional Vaccines: Vaccines Against Important Diseases That Will Not Be Available in the Next Decade
2. TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
3. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responses
4. Human TH1 and TH2 subsets: doubt no more
5. New meanings for an old word: adjuvanticity, cytokines and T cells
Cited by 189 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, Structural Characteristics, and Evaluation of the Antigen-Presenting Properties of Turpentine Oil Lyosol;BioNanoScience;2024-05-16
2. Gaston Ramon’s Big Four;Toxins;2024-01-09
3. Preclinical Toxicology of Vaccines;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024
4. Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations;Vaccines;2023-11-09
5. Autoimmune/autoinflammatory syndrome induced by adjuvants: a focus on silicone;Clinical Rheumatology;2022-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3